Amylyx

• Air pollution is associated with sex-specific longitudinal changes in astrocytic and neuroinflammatory processes linked to cognitive decline in Alzheimer's disease at-risk individuals

  Consulting or advice, Board or leadership role, 1 Oct 2026

• Blood-based biomarkers of Alzheimer's disease and neurodegeneration in an indigenous African cohort using both Simoa and NULISA platforms

  Consulting or advice, Board or leadership role, 2 Sept 2026

• Presymptomatic plasma biomarkers in autosomal dominant Alzheimer's disease: sequence and timing

  Consulting or advice, Board or leadership role, 24 Aug 2026

• Cognitive components derived from traditional neuropsychological tests and their associations with plasma p-tau217 and p-tau181 in mild cognitive impairment: a multisite analysis

  Consulting or advice, Board or leadership role, 12 Aug 2026

• Prediction of mild cognitive impairment progression using time-sensitive multimodal biomarkers

  Consulting or advice, Board or leadership role, 12 Aug 2026

• Plasma Biomarkers for Neocortical Tau Burden

  Consulting or advice, Fees or honoraria, Board or leadership role, 10 Aug 2026

• Lifestyle and psychosocial protective factors drive healthy aging and modulate inflammatory and metabolic pathways

  Consulting or advice, Board or leadership role, 5 Aug 2026

• Medial temporal ageing-related tau astrogliopathy below 66 years is associated with neurodegeneration

  Fees or honoraria, 3 Aug 2026

• Astrocyte reactivity modifies the effects of locus coeruleus norepinephrine-related dysfunction on tau and its impact on cognition

  Consulting or advice, Board or leadership role, 1 Aug 2026

• Predicting continuous amyloid PET levels with CSF and plasma brain-derived p-tau217

  Consulting or advice, Board or leadership role, 1 Aug 2026

• CSF fibrinogen predicts longitudinal Tau accumulation in cognitively unimpaired older adults

  Consulting or advice, Board or leadership role, 1 Aug 2026

• Interpreting p-tau217 on the ward: frailty and plasma biomarkers in acutely admitted older adults

  Consulting or advice, Board or leadership role, 1 Aug 2026

• Burden of Dementia in Europe, 1990-2023: a systematic analysis from the Global Burden of Disease Study 2023

  Grants or research support, 31 Jul 2026

• Age-related alterations in plasma biomarkers of relevance to Alzheimer's disease are attenuated in KLOTHO KL-VS heterozygotes

  Consulting or advice, Board or leadership role, 6 Mar 2026

• Unraveling the role of polyamine metabolism in postoperative delirium: insights into biochemical mechanisms and biomarker potential

  Consulting or advice, Board or leadership role, 21 Feb 2026

• Frailty and prognosis of biomarker-confirmed Alzheimer's disease: a Swedish, register-based, retrospective cohort study

  Consulting or advice, Board or leadership role, 17 Dec 2025

• Synaptic dysfunction and glial activation markers throughout aging and early neurodegeneration: a longitudinal CSF biomarker-based study

  Consulting or advice, Fees or honoraria, Board or leadership role, 17 Oct 2025

• Plasma p-tau217 identifies cognitively normal older adults who will develop cognitive impairment in a 10-year window

  Consulting or advice, Board or leadership role, 1 Feb 2025

• Combining plasma Aβ and p-tau217 improves detection of brain amyloid in non-demented elderly

  Consulting or advice, Fees or honoraria, 23 May 2024

Sources: pubmed.ncbi.nlm.nih.gov

• Semaglutide Improves Tissue-Specific Insulin Action and Reduces Liver Fat in Type 2 Diabetes with Spinal Cord Injury

  ADA Scientific Sessions 2026 abstract, 6 Jun 2026